Spectral Medical (TSE:EDT) Issues Earnings Results

Spectral Medical (TSE:EDT) issued its earnings results on Friday. The company reported C($0.01) earnings per share for the quarter, FiscalAI reports. The company had revenue of C$0.89 million during the quarter.

Spectral Medical Trading Up 5.1%

Shares of TSE EDT traded up C$0.07 during midday trading on Friday, hitting C$1.43. The stock had a trading volume of 72,250 shares, compared to its average volume of 51,094. The company has a market capitalization of C$419.59 million, a price-to-earnings ratio of -8.94 and a beta of 0.65. Spectral Medical has a 1-year low of C$0.77 and a 1-year high of C$1.84. The company has a quick ratio of 0.45, a current ratio of 0.61 and a debt-to-equity ratio of 26.03. The company has a fifty day moving average price of C$1.36 and a 200 day moving average price of C$1.36.

About Spectral Medical

Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The segments of the group are Spectral Medical Inc, which is the key revenue-generating segment that manufactures and sells its EAA diagnostic and certain proprietary reagents; Dialco Medical Inc segment; and Corporate.